Aquestive Therapeutics, Inc.AQ.STNASDAQ
Loading
Net Income Growth Under PressureDecelerating
Percentile Rank14
3Y CAGR-48.4%
5Y CAGR-39.7%
Year-over-Year Change
Year-over-year net income growth rate
3Y CAGR
-48.4%/yr
Annual compound
5Y CAGR
-39.7%/yr
Recent deceleration
Percentile
P14
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
2 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 1.65% |
| 2024 | 5.22% |
| 2023 | 54.15% |
| 2022 | 12.02% |
| 2021 | 16.19% |
| 2020 | 20.75% |
| 2019 | 72.71% |
| 2018 | -25.87% |
| 2017 | -13.39% |
| 2016 | 38.16% |